Arch. Pharm. Res. DOI 10.1007/s12272-014-0397-2

RESEARCH ARTICLE

Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities Yun-Yun Zhu • Xue Li • Heng-Yi Yu • Yu-Fang Xiong • Peng Zhang • Hui-Fang Pi Han-Li Ruan



Received: 11 January 2014 / Accepted: 8 April 2014 Ó The Pharmaceutical Society of Korea 2014

Abstract Three novel alkaloids (1–3), together with nineteen known ones (4–22), were isolated from the bulbs of Lycoris longituba. Their structures were elucidated on the basis of extensive spectroscopic analyses, which belong to several Amaryllidaceae alkaloid skeletons. Among them, the harmane-type alkaloids (the new compound 1 and the known compounds 5, 6 and 7) were found for the first time from Lycoris genus. The isolates were tested for their neuroprotective activities against CoCl2, H2O2 and Ab25–35-induced SH-SY5Y cell injuries, and the majority of them exhibited neuroprotective activities of different degrees. The acetylcholinesterase (AChE) inhibitory activities of the isolated alkaloids were also evaluated, while compounds 12, 14–20 and 22 exhibited extremely significant AChE inhibitory activities. Keywords Lycoris longituba  Alkaloid  Neuroprotective activity  AChE inhibitory activity

Introduction The Amaryllidaceae family consists of about sixty genera, whose eight hundred species are widely distributed in the

Y.-Y. Zhu  X. Li  H.-Y. Yu  P. Zhang  H.-F. Pi  H.-L. Ruan (&) Faculty of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, People’s Republic of China e-mail: [email protected] Y.-F. Xiong Department of Biochemistry, Tongji Medical College of Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, People’s Republic of China

tropics and warm-temperate regions of the world (Kornienko and Evidente 2008). Most plants of Amaryllidaceae are known to produce structurally unique alkaloids, which showed diverse bioactivities such as antiviral, acetylcholinesterase (AChE) inhibitory, antibacterial, antifungal, antineoplastic and antimalarial effects (Ieven et al. 1979; Louw et al. 2002; Sener et al. 2003; Elgorashi et al. 2004; Jin 2005; Jokhadze et al. 2007). Especially, galanthamine and lycorine types exhibited significant cholinesterase inhibitory effect, which enhances cognitive functions of Alzheimer’s patients (Lopez et al. 2002). AChE inhibitors are considered to be one of the most effective approaches for treating AD (Bartus et al. 1982; Perry 1986; Senol et al. 2010). The genus Lycoris from Amaryllidaceae consists of about 20 species all over the world, with 17 (including one variety) of which distributing in China. Recently, our group reported the chemical constituents and neuroprotective activities of several lycoris plants (Li et al. 2013; Jin et al. 2014; Wu et al. 2014). As a continuation of our work, another lycoris plant, Lycoris longituba, was studied in this paper. Lycoris longituba mainly grows in Jiangsu province (McNulty et al. 2007) and the bulbs of which have been traditionally used for the treatment of sore throats, furuncle carbuncle swollen in skin and scrofula (He et al. 2011). Previously, 12 alkaloids were isolated from the bulbs of L. longituba (Liang et al. 2010, Zhao et al. 2011), but the pharmacological studies on this plant have never been reported before. To discover potentially bioactive compounds, we further investigated the bulbs of L. longituba collected in Baohua Mountain, Jiangsu province. Accordingly, three new alkaloids (1–3): lycolongirine A (1), lycolongirine B (2), lycolongirine C (3), together with nineteen known ones (4–22), incartine (4) (Berkov et al. 2007), norharmane (5) (Abramovitch and Spenser 1964;

123

Y.-Y. Zhu et al.

11

H3C

10 8 8a N 9a

7

HO 1

O 1

H3CO 10

N

4b

5

4a

1

3

H

11 11b

9

O

3a

10a

8

H N

8

6a

7

6

8a

7

9a

N

8

2

6

4b

5

4a

6

4

10

H3CO H3CO

9

11c

H

7a

8

N 7

4

10

9

1

O

9

10 10b 10a

O

8

7

H3CO

9

7a

8

OMe 11 OH

3

H

3a 11c

5

6

7

O 4

N

N

6a

O

O

9

7a

8

N 6a 7

4

12

OH

OH

3

3

1 10b

4a 12 11

10

R3

R1

N R2

9

7 8

1 10b

4a 12 11

10

R

O

9

10 10b

O

8

R1

N R2 6

9

5

7

OMe 11 OH 3

4a

H

N

6a

7

6

OH

3

4

O

4

OCH3

6

6

R

11c

13a

2

4

3a

N

1

10a

CH3

6

11

3

H

2

10b 4a

6

O N

2

1

11 11b 10 11a H

3

10 9 10a

8

5

9

1

O

4

N

OCH3 HO

2

4

2

3

H

8

3

O

3a 11c

8 7a

9

Cl

OH 13b

O

4

7

4a

H

6a

3

10a

8

5

11a

2

11 11b 10 11a H

10b 4a

O

11 11b

OH H3CO 10

3

H

4

1

2

10

2

O

N

1

O

3 3a

H

11b 11a

1

9a

4a

OCH3 2 OH

3

2

1

OH HO

7

1

11

4b

5

5 R=H 6 R=CH3

HO

8a

7

3

H N

HO

3

O 1

4a

N H CH2Cl

HOH2C R

2

4

2

1

OCH3

OCH3

11 4b 12

H O HN 5 OCH H3CO 9 8 7a 3 OCH 3 7

4

10

OH

11c 4

11a

3

6

2

O

12

4a

13a

O

7

11

4

2 13 1

10

9

13b

H

N CH3

6a

6

OR 8

8

14 R=OCH3 R1=free R2=CH3 R3=H 19 R=OCH3 R1=CH2Cl R2=CH3 15 R=OCH3 R1=free R2=H R3=H 20 R=OH R1=free R2=CH3 16 R=OCH3 R1=CH2Cl R2=CH3 R3=H 17 R=OCH3 R1=free R2=CH3 R3=OH 18 R=OH R1=free R2=CH3 R3=H

21 R=OH 22 R=H

Fig. 1 The structures of compounds 1–22

Balkau and Heffernen 1973), harmane (6) (Hiroko et al. 1993), perlolyrine (7) (Li et al. 2011, 2012), lycorine (8) (Tsuda et al. 1979), hippamine (9) (Evidente et al. 1984), N-chloromethyl narcissidine (10) (Suau et al. 1990), trisphaeridine (11) (Alonso et al. 2010), N-methylcrinasiadine (12) (Cowden et al. 1994), (?)-haemanthidine (13a), (-)haemanthidine (13b) (Pabuccuoglu et al. 1989), galanthamine (14) (Kihara et al. 1994), N-norgalanthamine (15) (Treu and Jordis 2001), N-chloromethyl galanthamine (16)

123

(Matusch et al. 1994), 11b-hydroxy galanthamine (17) (Andrade et al. 2011), sanguinine (18) (Kihara et al. 1994), N-chloromethyl lycoramine (19) (Matusch et al. 1994), Odemethyllycoramine (20) (Wang et al. 2010), tazettine (21) (Roberts et al. 1971), deoxytazettine (22) (Roberts et al. 1971) were isolated (Fig. 1). The isolated alkaloids were tested for their neuroprotective activities against CoCl2, H2O2 and Ab25–35 induced SH-SY5Y cell injury. Compounds 11, 16, 17 and 22 exhibited significant

Alkaloids from the bulbs of Lycoris longituba

neuroprotective effects against CoCl2-induced SH-SY5Y cell injury, and compounds 1, 2 and 22 showed significant neuroprotective effects against H2O2-induced SH-SY5Y cell death, while compounds 16, 18 and 19 had similar activities against Ab25–35-induced SH-SY5Y cell damage. The isolated alkaloids were also tested for their acetylcholiesterase (AChE) inhibitory activities. And the compounds 12, 14–20 and 22 exhibited extremely significant AChE inhibitory activities.

Materials and methods General 1

H (400 MHz), 13C (100 MHz), and 2D-NMR spectra were recorded on a Bruker AM-400 spectrometer with tetramethylsilane (TMS) as an internal standard. Chemical shifts are in ppm (d), relative to TMS and scalar coupling constants (J) reported in Hertz and used deuterated dimethyl sulfoxide (DMSO-d6), methanol (CH3OH-d4) and chloroform (CHCl3-d), pyridine (pyridine-d5) as solvents. Electrospray ionization (ESI) mass spectra were acquired in the positive ion mode on an LCQ DECAXP instrument (Thermo Finnigan, San Jose, CA, USA) equipped with an ion trap mass analyzer. HR-ESI–MS were obtained in the negative ion mode on Thermo LTQ-Orbitrap XL. IR spectra were obtained on a NicoletTM 380 spectrometer from Thermo Electron; in cm-1. UV spectra were taken on a Cary-50 spectrophotometer. Optical rotations were acquired on a PerkinElmer PE-341L polarimeter. TLC plates were HSGF254 SiO2 from Yantai Jiangyou Silica Gel Development Co., Ltd., China. Column chromatography (CC) silica gel (SiO2; 200–300 mesh; Qingdao Haiyang Chemical Co., Ltd., Qingdao, China). All other Organic solvents were of analytical reagent grade from Traditional Chinese medicine group. Plant material The fresh bulbs of L. longituba were collected in the Baohua Mountain, Zhenjiang city of Jiangsu Province, China, in September 2011 and identified by Prof. Shulan He of Zhongshan botanical garden. A voucher specimen (20110909) has been deposited in the Herbarium of Materia Medica Faculty of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

atmosphere with 5 % CO2 incubator. The samples were solved and diluted with PBS to required concentrations. The cell viability was assessed using a MTT assay. About 9 9 103 cells in 1 mL of logarithmic phase were seeded onto a 96-well microplate. 24 Hours later, each hole with 11.5 lL sample to be tested in the normal group, while 11.5 lL PBS in control group. After 2 h, CoCl2, H2O2 or Ab25–35 was added to the normal group and control group. 15 lL of MTT solution (5 mg/mL) was added to all of the holes after the cells were cultured at 37 °C for 24 h. After continuing to culture for 4 h, the medium was removed and DMSO (100 lL/well) was added. Finally, the reduced MTT was assayed at 570 nm using a multi-function microplate reader. AChE inhibition assay AChE from electric eel (type VIS), acetylthiocholine iodide and 5, 5-dithio-bis (2-nitrobenzoic acid) (DTNB) was purchased from Sigma. AChE inhibitory activities of the isolated compounds were determined using Ellman’s colorimetric method (Ellman et al. 1961) as modified by Eldeen et al. (2005). 25 lL of 15 mM ATCl in water, 125 lL of 3 mM DTNB in Buffer C (50 mM Tris–HCl, pH 8.0, 0.1 M NaCl and 0.02 M MgCl2. 6H2O), 50 lL Buffer B (50 mM Tris–HCl, pH 8.0, 0.1 % bovine serum albumin) and 25 lL of the samples (6.25, 12.5, 25, 50 lM, 100 Lm) were added to the wells in a 96 wells microplate. Absorbance corresponding to spontaneous hydrolysis was read at 405 nm every 45 s for 5 times. Thereafter, 25 lL of 0.20 U/mL AChE was added to each well and absorbance was consecutively read again every 45 s for 9 times. Galanthamine served as the positive control. Any increase in absorbance due to the spontaneous hydrolysis of the substrate was corrected by subtracting the absorbance before adding the enzyme from the absorbance after adding the enzyme. The percentage inhibition was calculated   using the equation inhibition ð%Þ ¼ Acontrol  Asample = Acontrol   100. Where Asample is the absorbance of the sample and Acontrol is the absorbance of the blank (Buffer A). AChE inhibition values are means of three individual determinations each performed in triplicate. AChE inhibitory activity expressed as IC50 values were obtained from the logarithmic non-linear regression curve derived from the plotted data using GraphPad Prism software package for Windows (GraphPad version 5.0, San Diego, USA).

Statistical analysis Neuroprotective activity assay SH-SY5Y cells were cultured in DMEM high glucose medium containing 10 % FBS at 37 °C in a humidified

Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by post hoc multiple comparisons using the Newman–Keuls Multiple Comparison

123

Y.-Y. Zhu et al. Table 1 1H NMR (400 MHz) and and 2 in CH3OH-d4

13

Compound 1 position

dC

1

150.5

dH (mult., J, Hz)

2a

C NMR (100 MHz) Data for 1

138.6

8.18 (1H, d, 5.3)

3a 116.1

4a

132.5

7.95 (1H, d, 5.3)

4b

123.3

5

123.6

8.13 (1H, d, 8.0)

6

121.9

7.23 (1H, t, 8.0)

7

130.8

7.53 (1H, t, 8.0)

7a 8

Compound 3

dH (mult., J, Hz)

position

dC

62.0

4.70 (1H, brd, 11.2)

1

118.9

5.90 (1H, brs)

53.0

3.71 (1H, ddd, 14.8, 4.1, 1.7)

2

78.3

3.54 (1H, m)

3.63 (1H, brd, 14.8)

3 4a

66.8 28.1

4.20 (1H, m) 2.63 (1H, dt, 11.2, 4.3)

8a

125.5

5.81 (1H, brd, 1.5)

4b

69.1

4.60 (1H, brs)

82.1

3.61 (1H, dd, 5.7, 2.8)

73.9

4.43, 4.38 (each 1H, d, 10.8)

130.5 114.2

7.62 (1H, d, 8.0)

115.4

6.94 (1H, s)

143.7

9

148.6

9a

135.2

10

72.6

5.33 (1H, q, 6.6)

150.1

11

24.5

1.64 (3H, d, 6.6)

114.5

7.36 (1H, s)

11a

133.5

11b

46.5

3.21 (1H, dd, 1.7, 11.2)

11c

74.2

4.00 (1H, brs)

(C-5)OCH3

58.1

3.45 (3H, s)

(C-7)OCH3

58.3

3.37 (3H, s)

(C-9)OCH3

56.6

3.82 (3H, s)

(C-10)OCH3

56.4

3.88 (3H, s)

method. The data are expressed as mean ± SEM of three assays. Extraction and isolation The fresh bulbs of L. Longituba (45 kg) were cut into pieces and extracted exhaustively with ethanol (95 %) for five times (2 h each time) at 55 °C in multi-function extraction tank. The solvent was evaporated under vacuum and the liquid extract was acidified to pH 3–4 by HCl and then extracted with CH2Cl2 for five times to afford 850 g of acid extract. After adjusting the pH value of the remaining parts to neutral by addition of NaOH, 69 g neutral components were resulted. The last part was alkalified to pH 10–11 and 13–14 successively, produce 152 g and 135 g alkaline substances, respectively. The four CH2Cl2 fractions of different pH were put together and concentrated to afford a residue, which was subjected to silica gel (200–300 mesh), and eluted with a gradient system of CH2Cl2/CH3OH (1:0, 70:1, 50:1, 30:1, 20:1, 10:1, 8:1, 6:1,

123

C NMR (100 MHz) Data for 3

dC

143.2

4

13

Compound 2

2b 3

Table 2 1H NMR (400 MHz) and in CH3OH-d4

dH (mult., J, Hz)

2.02 (1H, td, 11.9, 2.4)

4a

72.3

4b

144.1

6a

66.2

6b

4.59 (1H, brd, 11.6) 4.96 (1H, d, 15.1), 5.12 (1H, d, 15.1)

6a

119.1

7

107.7

8

149.5

9

149.6

10

108.1

10a

129.2

11

45.3

4.09 (1H, brd, 3.1)

12a

64.4

4.00 (1H, d, 10.2)

103.1

5.96 (2H, d, 0.9)

12b (C-8, 9)OCH2O

6.76 (1H, s)

6.84 (1H, s)

3.84 (1H, ddd, 1.7, 3.1, 10.2)

(C-2)OCH3

58.2

3.44 (3H, s)

N–CH2Cl

66.5

5.61, 5.59 (each 1H, d, 10.1)

4:1, 1:1, 0:1, V/V) to yield fractions A–I according to TLC analysis. The fraction A was chromatographed over a series of silica gel and Sephadex LH-20 (CH2Cl2/CH3OH 1:1) to afford compound 11 (31 mg) and compound 12 (25 mg). Fraction B was separated into four parts (B-1 to B-4) by silica gel. The part B-2 was again subjected to silica gel to give six subfractions (B-2-1 to B-2-6). Among them, subfractions B-2-3 and B-2-4 were further purified with Sephadex LH-20 (MeOH) and then high performance liquid chromatography (HPLC) to yield the new compound 1 (12.7 mg) and compound 5 (12.6 mg), respectively. Subfraction B-2-5 was obtained as compound 6 (16.7 mg). The part B-3 was subjected to Sephadex LH-20 (MeOH) and then silica gel again to get four subfractions (B-3-1 to B-3-4). Subfraction B-3-2 was produced compound 7 (15.6 mg) and 14 (10.2 mg) by HPLC. Subfraction B-3-3 was afforded compound 21 (15 g). Fraction C was resulted in compound 22 (19.7 mg). The Fractions D–I were applied on Sephadex LH-20 (CH2Cl2/CH3OH 1:1 or 0:1), TLC and HPLC to produce compound 3 (29.7 mg), 4 (18.0 mg) and the others. Lycolongirine A (1) light yellow powder; [a]20 D ? 9.35°(c 0.42, CH3OH); UV k max (CH3OH) nm (log e):

Alkaloids from the bulbs of Lycoris longituba Fig. 2 Key correlations of compound 1

H3C O N N

1

H-1H-COSY

Key NOESY correlations

HMBC H to C Fig. 3 Key correlations of compound 2

HO

H3CO

OH

HN H3CO

OCH3

OCH3

1

H-1H-COSY

Key NOESY correlations

HMBC H to C

235 (0.71), 289 (0.33), 340 (0.09); IR (KBr) t max cm-1: 3089, 2970, 2838, 1625, 1588, 1430, 1371, 1221, 740; 1HNMR and 13C-NMR data: see Table 1; Positive HR-ESI– MS m/z: 211.0868 [M ? H]? (calc. for C13H11N2O?, 211.0871). Lycolongirine B (2) yellow oil; [a]20 D ? 25.71°(c 1.39, CH3OH); UV k max (CH3OH) nm (log e): 206 (1.42), 236 (0.36), 282 (0.13); IR (KBr) t max cm-1: 3471, 2932, 2829, 1606, 1517, 1464, 1370, 1285, 1188, 1111, 937; 1H-NMR and 13C-NMR data: see Table 1; Positive HR-ESI–MS m/z: 366.1906 [M ? H]? (calc. for C19H28NO6?, 366.1917). Lycolongirine C (3) colorless needles; [a]20 D ? 26.68° (c 1.13, CH3OH); UV k max (CH3OH) nm (log e): 212 (2.21), 244 (0.41), 291 (0.52); IR (KBr) t max cm-1: 3383, 3027, 2959, 2826, 1636, 1507, 1488, 1247, 937; 1H-NMR and 13C-NMR data: see Table 2; Positive HR-ESI–MS m/z: 350.1152 [M]? (calc. for C18H21ClNO4?, 350.1154). Results and discussion Compound 1 was isolated as light yellow powder, [a]20 D ? 9.35°(c 0.42, CH3OH). Its molecular formula was established as C13H10N2O by HR-ESI–MS from the

[M ? H]? ion peak at m/z 211.0868 [M ? H]? (calc. 211.0871), indicating ten degrees of unsaturation. The 1HNMR spectrum of 1 exhibited the presence of a 1, 2-substituted benzene at dH 8.13 (1H, d, J = 8.0 Hz, H-5), 7.62 (1H, d, J = 8.0 Hz, H-8), 7.53 (1H, t, J = 8.0 Hz, H-7) and 7.23 (1H, t, J = 8.0 Hz, H-6), an ortho-positioned pyridine at dH 8.18 (1H, d, J = 5.3 Hz, H-3) and 7.95 (1H, d, J = 5.3 Hz, H-4), a methyl at dH 1.64 (3H, d, J = 6.6 Hz) and an O-methine at dH 5.33 (1H, q, J = 6.6 Hz, H-10) (Table 1). In turn, the 13C-NMR and DEPT spectra of 1 showed 13 carbon signals [CH3 9 1, CH (sp3) 9 1, CH (sp2) 9 6 and C (sp2) 9 5, Table 1]. The existence of an –OCHCH3 moiety was supported by the 1H–1H–COSY spectrum (Fig. 2). The NMR spectral characteristics of 1 were very similar to those of harmane (Hiroko et al. 1993), except that the methine carbon (C-10) on the –OCHCH3 linked with N-9, wherever the oxygen of the –OCHCH3 linked to C-1 to form a five-membered ring in 1. The above conclusion was confirmed by the HMBC experiment (Fig. 2). The stereochemical structure of 1 was speculated as the form showed in Fig. 2, which was supported by its positive specific rotation ([a]20 D ? 9.35°) (Bandini et al. 2008; Stanley and Hartwig 2009). According to references (Bandini et al. 2008; Stanley and Hartwig

123

Y.-Y. Zhu et al.

Fig. 4 Key correlations of compound 3

Table 3 Cell viabilities (%) of compounds in different concentrations in H2O2 induced SH-SY5Y cells injuries Compound

6.25 1

300 lM

Test concentration (lM) 12.5

81.50 ± 1.58

2 3

b

60.89 ± 0.10 90.41 ± 0.90b

4

81.01 ± 1.15a

25

50

100

H2O2

94.53 ± 0.15c

89.58 ± 0.82c

84.52 ± 0.35c

73.97 ± 1.80

74.39 ± 0.47

b

59.50 ± 0.31 83.63 ± 1.19a

a

57.10 ± 0.21 78.34 ± 0.61

56.14 ± 0.10a 74.26 ± 0.95

55.33 ± 0.55a 68.84 ± 0.92

51.54 ± 0.53 72.64 ± 0.25

93.72 ± 1.00c

83.25 ± 0.21b

81.56 ± 0.64b

76.86 ± 0.99

74.81 ± 0.70 51.52 ± 0.86

b

5

54.71 ± 0.85

59.97 ± 0.82

52.23 ± 0.40

51.11 ± 0.95

44.61 ± 0.68

6

78.99 ± 0.85a

89.38 ± 0.50c

91.73 ± 0.93b

81.60 ± 0.97b

70.14 ± 0.81

74.39 ± 0.47

7

55.18 ± 0.42

62.24 ± 0.25b

48.40 ± 0.62

32.19 ± 0.42

12.11 ± 0.58

51.20 ± 0.86

8

59.61 ± 0.85

58.37 ± 0.82

53.63 ± 0.46

50.11 ± 0.75

44.45 ± 1.08

67.48 ± 0.98

9

60.75 ± 0.67

82.97 ± 0.47b

95.36 ± 0.45c

94.23 ± 0.54c

84.75 ± 0.38b

63.46 ± 1.42

10

67.82 ± 0.91

72.89 ± 0.10

78.10 ± 1.14

70.08 ± 0.38

67.72 ± 0.1

72.86 ± 0.21

11

66.70 ± 0.85a

75.50 ± 0.68b

70.69 ± 0.31c

73.14 ± 0.60b

66.61 ± 0.85a

59.66 ± 0.15

12

65.70 ± 2.02

75.54 ± 1.81b

71.01 ± 0.51b

68.51 ± 1.07a

59.30 ± 0.45

59.66 ± 0.15

13

68.21 ± 1.25

78.09 ± 0.29b

67.27 ± 0.86

64.70 ± 0.72

54.19 ± 0.93

70.43 ± 0.46

14

63.70 ± 0.95a

63.85 ± 0.68a

71.69 ± 0.31b

65.74 ± 1.60b

63.31 ± 1.85a

49.66 ± 0.15

c

15

73.18 ± 0.55

77.53 ± 0.35

71.37 ± 0.78

59.90 ± 0.44

67.51 ± 0.89

70.43 ± 0.46

16

75.95 ± 0.90

93.35 ± 0.31c

87.70 ± 0.62c

83.55 ± 1.10b

79.29 ± 0.42a

74.81 ± 0.70

17

67.03 ± 0.44

73.41 ± 0.44

79.20 ± 0.15c

75.12 ± 0.40a

73.30 ± 0.36

72.86 ± 0.21

18 19

67.93 ± 0.40b 82.25 ± 0.78b

70.07 ± 0.38c 82.81 ± 0.25c

74.03 ± 0.35c 83.73 ± 0.47c

76.83 ± 0.23c 83.93 ± 0.69c

69.08 ± 0.15c 85.53 ± 0.40b

57.72 ± 0.25 72.26 ± 0.32

20

64.58 ± 0.35b

68.48 ± 0.45b

69.91 ± 0.31c

73.53 ± 0.59b

65.95 ± 0.32c

57.72 ± 0.25

b

c

b

75.69 ± 0.40

72.17 ± 0.38

80.02 ± 0.97a

72.64 ± 0.25

83.48 ± 0.62b

72.17 ± 0.38

21

68.41 ± 0.40

74.47 ± 0.59

78.03 ± 0.26

79.77 ± 0.31

22

83.03 ± 0.78b

92.91 ± 0.66c

84.48 ± 0.68b

82.14 ± 0.38c

Vitamin E

2009), for similar structures like compound 1, when the configuration of the carbon linked to the nitrogen (C-10) is R, the optical rotation is positive. Thus, 1 was assigned as (?)-(R)-1-methyl-1H-2-oxa-3,9b-diazacyclopenta [jk] fluorine, and given the name lycolongirine A. Compound 2 was obtained as yellow oil, [a]20 D ? 25.71°(c 1.39, CH3OH). The HR-ESI–MS revealed

123

quasimolecular ion peaks at m/z 366.1906 (calc. for C19H28NO6?, 366.1917) [M ? H]?, and m/z 731.3740 (calc. for C38H55N2O12?, 731.3755) [2 M ? H]?, corresponding to the molecular formula C19H27NO6 with 7 degrees of unsaturation. The 1H-NMR spectrum of 2 (Table 1) revealed two singlets for the para-oriented aromatic protons at dH 7.36 (H-11) and 6.94 (H-8), one

Alkaloids from the bulbs of Lycoris longituba Table 4 Cell viabilities (%) of compounds in different concentrations in Ab25–35 induced SH-SY5Y cells injuries Compound

1 lM

Test concentration (lM) 6.25

12.5

25

1

63.33 ± 1.08

76.52 ± 0.21c

75.14 ± 0.64b

72.85 ± 0.38

68.69 ± 0.31

67.71 ± 0.21

2

78.27 ± 0.83

74.07 ± 0.83

72.04 ± 0.45

60.43 ± 0.35

54.70 ± 0.49

74.39 ± 0.53

3

68.05 ± 0.42b

64.51 ± 0.44

63.10 ± 0.31

61.21 ± 0.32

a

50

b

100

Ab25–35

52.85 ± 0.51

58.12 ± 0.30

b

74.84 ± 0.83

74.39 ± 0.53

4

72.63 ± 0.78

78.59 ± 0.46

81.26 ± 0.61

87.13 ± 0.17

5

58.24 ± 0.42

60.99 ± 0.76

68.28 ± 1.14

72.77 ± 1.03b

62.59 ± 0.95

63.85 ± 0.97

6

68.03 ± 0.91

64.44 ± 0.71

62.51 ± 0.57

59.77 ± 0.75

54.83 ± 0.78

67.30 ± 1.14

7 8

55.84 ± 0.47 60.31 ± 0.85

60.64 ± 0.97a 57.47 ± 0.82

50.68 ± 0.35 51.73 ± 0.46

46.64 ± 0.49 48.31 ± 0.76

9.67 ± 0.15 43.45 ± 1.18

54.35 ± 0.65 67.48 ± 0.98

9

65.81 ± 0.37

75.51 ± 0.71b

73.47 ± 0.56b

72.29 ± 0.95b

68.35 ± 0.84

65.46 ± 0.49

62.80 ± 0.17

59.63 ± 0.87

49.69 ± 0.60

63.85 ± 0.97 58.12 ± 0.30

a

10

68.21 ± 0.95

63.51 ± 0.30

11

62.26 ± 0.50b

69.53 ± 0.32c

64.43 ± 0.31c

63.42 ± 0.26c

61.17 ± 0.12b

12

b

70.92 ± 0.40

73.94 ± 0.78

c

b

b

68.12 ± 0.15b

59.33 ± 0.74

13

73.55 ± 0.67c

59.29 ± 0.86

14

80.68 ± 1.40 c

72.94 ± 0.25

69.26 ± 0.36

52.73 ± 1.27

46.60 ± 0.96

43.86 ± 0.53

59.33 ± 0.74

85.94 ± 1.78c

86.90 ± 1.25c

79.26 ± 0.36

78.12 ± 0.15

77.13 ± 0.74

c

77.51 ± 0.20c

75.45 ± 0.25c

73.95 ± 0.15c

62.33 ± 0.30

15

73.20 ± 0.51

73.98 ± 0.44

16

65.00 ± 0.55b

70.13 ± 0.72c

73.38 ± 0.32b

69.15 ± 0.31b

59.55 ± 0.26a

53.92 ± 0.36

17

66.80 ± 0.31

80.13 ± 0.32c

77.60 ± 0.36c

75.43 ± 0.40b

73.50 ± 0.15c

67.71 ± 0.21

18

76.14 ± 0.98a

78.30 ± 0.38b

82.52 ± 0.68c

76.50 ± 0.06a

72.96 ± 0.55

70.25 ± 0.70

19

73.31 ± 0.21c

81.79 ± 0.36c

85.14 ± 0.21c

78.23 ± 0.21c

70.49 ± 0.35c

62.33 ± 0.30

20

68.39 ± 0.31b

78.09 ± 0.32c

72.41 ± 0.26c

70.85 ± 0.30c

66.72 ± 0.25b

63.02 ± 0.21

21

b

73.08 ± 0.49

82.86 ± 0.51

c

c

b

70.66 ± 0.35

63.02 ± 0.21

22 Vitamin E

60.38 ± 0.78a

62.49 ± 0.30c

55.25 ± 0.42 69.92 ± 0.55b

53.92 ± 0.36 63.02 ± 0.21

75.83 ± 0.15

72.92 ± 0.50

66.13 ± 0.44c

60.73 ± 0.44b

olefinic proton at dH 5.81 (1H, brd, 1.5, H-3), four methoxy groups at dH 3.88 (3H, s), 3.82 (3H, s), 3.45 (3H, s) and 3.37 (3H, s), two AB system CH2 at dH 4.43 (1H, d, J = 10.8 Hz, H-7a) and 4.38 (1H, d, J = 10.8 Hz, H-7b), dH 3.71 (1H, ddd, J = 14.8, 4.1, 1.7 Hz, H-2a) and 3.63 (1H, brd, J = 14.8 Hz, H-2b), respectively. The 13C-NMR (Table 1) and DEPT spectra of 2 displayed 19 carbon signals [OCH3 9 4, CH2 (sp3) 9 2, CH (sp3) 9 5, CH (sp2) 9 3 and C (sp2) 9 5, Table 1]. From the NMR evidences, compound 2 has one benzene and one olefinic group in the structure, needing two more rings to meet the need of the unsaturation. The above spectral characteristics of 2 were very similar to those of lycorine-type alkaloid (Tsuda et al. 1979) with one ring splitting. The HMBC spectrum revealed that a –CH2OCH3 fragment was connected on C-7a, with C-7 and N-6 splitting from the ring (Kitagawa et al. 1959). The 1H–1H–COSY spectrum of 2 revealed the presence of a CH–CH–CH (OH)–CH2–CH=C and a CH (OCH3)–CH (OH) fragments, respectively. The HMBC correlation of H-5 (dH 3.61) with 5-OCH3 (dC 58.1) suggested that the methoxy group was connected on C-5. Accordingly, the two hydroxy groups were connected on C-1 (dC 62.0) and C-4 (dC 69.1), respectively. These

substitutions were demonstrated by the 1H–1H–COSY and HMBC spectra (Fig. 3). From above analysis, the planar structure of 2 was deduced unambiguously to be the structure as shown in Fig. 3. In the NOESY spectrum (Fig. 3), the H-11c signal gave a correlation with H-4 and H-5, while showing no correlation with H-1.The relative configurations of H-11c and H-11b in 2 was assigned as aand b-orientations, respectively, which was always appeared in the lycorine-type alkaloids isolated from the genus Lycoris (Evidente et al. 1983). So H-1 was deduced as b-orientation, H-4 and H-5 was a-orientation. Thus, the structure of 2 was identified as (2R,3R,6R,7S,7aS)-7-(4,5dimethoxy-2-(methoxymethyl)phenyl)-2-methoxy-2,3,5,6,7, 7a-hexahydro-1H-indole-3,6-diol, named lycolongirine B. Compound 3, colorless needles, [a]20 D ? 26.68° (c 1.13, CH3OH). The HR-ESI–MS of 3 displayed a molecular ion at m/z 350.1152 [M]?, being consistent with a molecular formula of C18H21ClNO4? (calc. 350.1154) and corresponding to 9 degrees of unsaturation. Inspection of the 1H-NMR (Table 2) spectrum of 3 revealed the presence of 20 protons, including two singlets for the paralocated aromatic protons at dH 6.84 (H, s, H-10) and 6.76 (H, s, H-7), an olefinic proton at dH 5.90 (H, s, H-1), a

123

Y.-Y. Zhu et al. Table 5 Cell viabilities (%) of compounds in different concentrations in CoCl2 induced SH-SY5Y cells injuries Compound

265 lM

Test concentration (lM) 6.25

12.5

25

50

84.52 ± 0.21c

81.34 ± 0.55b

77.61 ± 0.61a

74.69 ± 0.57

74.10 ± 0.45

51.76 ± 0.50

39.57 ± 0.25

28.31 ± 0.21

54.44 ± 0.32

83.14 ± 0.49c

74.14 ± 0.68a

65.96 ± 0.55

70.82 ± 0.72

b

74.51 ± 0.55

73.84 ± 0.47

b

70.75 ± 0.61

68.03 ± 0.21

70.39 ± 0.42b

62.56 ± 0.91

37.73 ± 0.36

64.47 ± 0.53

80.58 ± 0.0c

76.41 ± 0.20a

72.54 ± 0.36

74.10 ± 0.45

74.26 ± 0.42 50.73 ± 0.76

49.81 ± 0.68 46.31 ± 0.86

9.50 ± 0.60 42.47 ± 0.67

64.47 ± 0.53 67.48 ± 0.98

70.76 ± 0.67c

81.12 ± 0.72c

49.32 ± 0.49

67.69 ± 1.16

58.90 ± 0.47

36.99 ± 0.46

59.71 ± 0.65

90.91 ± 0.86c

80.26 ± 1.23a

75.15 ± 0.50b

70.26 ± 0.42

68.39 ± 0.25

64.12 ± 0.12

63.25 ± 0.32

70.26 ± 0.42

48.21 ± 1.47

1

78.27 ± 0.21b

2

a

61.67 ± 0.66

54.86 ± 0.50

3

69.72 ± 0.40

71.68 ± 0.64 c

4

66.47 ± 1.00

83.14 ± 0.40

5

53.81 ± 0.76

62.68 ± 0.1

6

80.65 ± 0.21b

88.65 ± 0.42c a

c

7 8

59.56 ± 0.21 60.54 ± 0.65

68.35 ± 0.62 55.46 ± 0.52

9

55.98 ± 0.81a

65.78 ± 0.58b

66.91 ± 0.57b

c

a

10

66.39 ± 2.12

71.97 ± 0.50

11

71.86 ± 0.32

92.63 ± 087c

12

70.91 ± 0.31

82.59 ± 0.35

13

54.89 ± 0.60

51.12 ± 0.55

c

100

CoCl2

36.80 ± 0.45

34.93 ± 0.20

70.94 ± 0.15

b

14

65.18 ± 0.89

66.78 ± 0.58

73.31 ± 0.97

69.76 ± 1.67

62.12 ± 0.72

63.47 ± 1.49

15

66.50 ± 0.49

70.17 ± 1.22

86.15 ± 0.83b

70.90 ± 0.85

61.33 ± 0.65

70.49 ± 0.15

16

58.44 ± 0.42

91.46 ± 0.20c

73.94 ± 1.08a

70.63 ± 0.50a

63.55 ± 0.15

66.72 ± 0.40

17

61.11 ± 0.15

83.03 ± 0.21c

71.57 ± 0.40c

68.33 ± 0.60b

54.26 ± 0.32

59.71 ± 0.65

18

64.42 ± 0.42a

69.37 ± 0.12b

78.77 ± 0.21b

71.42 ± 0.67b

66.25 ± 0.30b

60.53 ± 0.58

19

59.75 ± 0.26

65.89 ± 0.21c

67.23 ± 0.31b

69.52 ± 0.25c

68.71 ± 0.21c

58.49 ± 0.10

20

63.31 ± 1.11

68.09 ± 0.21

b

c

78.90 ± 0.42

70.10 ± 0.56

b

a

65.10 ± 0.70

60.53 ± 0.58

21

58.25 ± 0.38

79.90 ± 0.26c

83.33 ± 0.42c

81.87 ± 0.21c

79.86 ± 0.23c

69.68 ± 0.35

22 Vitamin E

76.57 ± 0.76b

91.95 ± 0.61c

81.05 ± 0.91b

77.96 ± 0.26b

63.75 ± 1.28 78.69 ± 0.87b

70.82 ± 0.72 70.82 ± 0.72

In Tables 3, 4 and 5, the activity was quantified in terms of OD570, shown as a percentage of the value with no inhibitor, taken as 100 %. All data were analyzed by one way ANOVA followed by Dunnett’s ‘t’ test (n = 3) with a kind of statistical software PASW statistics 18.0, a for p \ 0.05, b for p \ 0.01, c for p \ 0.001

methylenedioxy group at dH 5.96 (2H, d, J = 0.9 Hz, H-13), a chloromethyl group at dH 5.61 and 5.59 (each 1H, d, J = 10.1 Hz). The 13C-NMR and DEPT spectra of 3 exhibited 18 carbon signals [CH3 9 1, CH2 (sp3) 9 5, CH (sp3) 9 4, CH (sp2) 9 3 and C (sp2) 9 5, Table 2]. The 1 H–1H–COSY and HMBC spectra of 3 (Fig. 4) revealed the presence of a –CH2CH(O)CH(O)– and a = CH– CH(O)– fragments. The above NMR data as well as the positive optical rotation of 3 are similar to those of the known compound (?) coccinine (Jin and Weinreb 1997) except that 3 has an extra chloromethyl group at dH 5.51, 5.59 (each 1H, d, J = 10.1 Hz) and dC 66.5. The HMBC (Fig. 4) correlations between the two choloromethyl protons and C-4a, C-6, C-12, as well as the deshielding chemical shifts of H-4a, H-6, H-12 in the 1H NMR and C-4a, C-6, C-12 in the 13C NMR suggested the location of the chloromethyl group at N atom (Jin and Weinreb 1997). The NOESY correlations of H-2/H-4a and H-3/H-4a suggested H-2, H-3 and H-4a to be the same a-orientation. No correlation between H-11 and H-4a proved 11-CH2 to be borientation (Pearson and Lian 1998) (Fig. 4). Finally, the

123

structure of 3 was confirmed to be (?)-N-methylchloride coccinine, given the name lycolongirine C. As galanthamine easily forms a quaternary ammonium salt ((-)-N-(choloromethyl) galanthaminium chloride) by reaction with the solvent CH2Cl2 (Matusch et al. 1994), which was also used in our separation process, compound 3 could also be an artificial product. The isolated alkaloids were tested for their neuroprotective effects against CoCl2, H2O2 and Ab25–35-induced neuronal cell death in dopaminergic neuroblastoma SHSY5Y cells. Compounds 4, 6, 11, 16, 18, 20 and 22 showed significant neuroprotective effects against all three cell injury models; compounds 1-3 and 12 exhibited significant neuroprotective activities against H2O2 (Table 3) and Ab25–35-induced cell death (Table 4); while compounds 13, 15 and 17 had similar activities against CoCl2induced cell damage (Table 5). The above results provide a preliminary indication that Amaryllidaceae alkaloids may have a big potential to neuroprotective activities against both hypoxic injury and oxidative damage in neuronal cells.

Alkaloids from the bulbs of Lycoris longituba Table 6 AChE inhibitory activity of the isolated compounds (n = 3) Compound

Percent inhibitory activity (%)

IC50 (lM)

1

38.59 % ± 3.27

241.50 ± 2.46

2

37.11 % ± 2.69

157.40 ± 3.51

3

45.05 % ± 2.46

117.60 ± 1.79

4

41.08 % ± 0.85

148.70 ± 1.46

5

45.44 % ± 1.33

164.10 ± 1.59

6

57.29 % ± 0.82

77.10 ± 1.65

7

34.76 % ± 2.80

181.00 ± 4.00

8

32.36 % ± 2.34

224.80 ± 3.01

9

42.36 % ± 2.02

194.80 ± 2.31

10

36.43 % ± 3.23

151.10 ± 2.42

11 12

33.00 % ± 0.91 84.91 % ± 0.59

190.70 ± 2.00 4.23 ± 1.13

13

38.96 % ± 0.78

208.10 ± 1.58

15

91.50 % ± 0.67

2.76 ± 0.65

16

93.51 % ± 0.87

5.55 ± 0.63

17

96.05 % ± 0.45

3.04 ± 0.61

18

92.63 % ± 0.15

5.30 ± 0.76

19

78.78 % ± 0.93

25.76 ± 1.09

20

85.63 % ± 0.61

8.13 ± 1.49 275.10 ± 1.86

21

32.22 % ± 1.58

22

89.44 % ± 0.38

8.44 ± 0.83

Galanthamine (14)

94.54 % ± 0.51

2.43 ± 0.66

IC50 value represents the concentration of compounds required to inhibit the 50 % activity of AChE. The percent inhibitory activity (%) represents inhibitory activity of compound in the concentration of 100 lM. ‘‘±’’ represents standard error of mean of these enzyme inhibition assays. Galanthamine was used as positive control

The isolates were also evaluated for their in vitro AChE inhibition according to a modified Ellman method (Eldeen et al. 2005) using galanthamine as a positive control. Compounds 12, 15-18, 20 and 22 were found to exhibit strong AChE inhibitory effects with IC50 values ranging from 2.76 to 8.44 lM (Table 6). The observed AChE inhibitory effects (Table 6) seem to be related to some structural characteristics among the different skeleton types. Only the alkaloids belonging to the galanthamine (compounds 15–20), the narciclasine (compound 12), and tazettine (compound 22) types exhibited significant AChE inhibitory activities. While the harmane-type alkaloid compound 6 (harmane) was also found to have moderate anti-AChE activity with the IC50 of 77.10 lM (Table 6). Our results indicated that except of the galantamine-type, the narciclasine and tazettine type alkaloids also have great potential of anti-AChE activity. Acknowledgments Financial supports from the Ministry of Science and Technology of the People’s Republic of China (International Cooperative Project, Grant No. 2010DFA32430) and Natural Science

Foundation of China (No. 81072547, 31270394 and 30873361) are gratefully acknowledged. Conflict of interest All the authors have no conflict of interest to declare.

References Abramovitch, R.A., and I.D. Spenser. 1964. The nuclear magnetic resonance spectra of the carbolines. Canadian Journal of Chemistry 42: 954–956. Alonso, R., A. Caballero, P.J. Campos, and M.A. Rodr I Guez. 2010. Photochemistry of acyloximes: Synthesis of heterocycles and natural products. Tetrahedron 66: 8828–8831. Andrade, J.P., S. Berkov, F. Viladomat, C. Codina, J.A.S. Zuanazzi, and J. Bastida. 2011. Alkaloids from hippeastrum papilio. Molecules 16: 7097–7104. Balkau, F., and M.L. Heffernen. 1973. NMR spectra of the carbolines. I. Spectral parameters. Australian Journal of Chemistry 26: 1501–1522. Bandini, M., A. Eichholzer, M. Tragni, and A. Umani-Ronchi. 2008. Enantioselective phase-transfer-catalyzed intramolecular azamichael reaction: Effective route to pyrazino-indole compounds. Angewandte Chemie 120: 3282–3285. Bartus, R.T., R.R. Dean, B. Beer, and A.S. Lippa. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–414. Berkov, S., R. Reyes-Chilpa, C. Codina, F. Viladomat, and J. Bastida. 2007. Revised NMR data for incartine: An alkaloid from Galanthus elwesii. Molecules 12: 1430–1435. Cowden, C.J., M.G. Banwell, and I.C. Ho. 1994. Synthesis of the putative structure of 5, 6-dihydrobicolorine. Journal of Natural Products 57: 1746–1750. Eldeen, I.M., E.E. Elgorashi, and J. van Staden. 2005. Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. Journal of Ethnopharmacology 102: 457–464. Elgorashi, E.E., G.I. Stafford, and J. van Staden. 2004. Acetycholinesterase enzyme inhibitory effects of amaryllidaceae alkaloids. Planta Medica 70: 260–262. Ellman, G.L., K.D. Courtney, V.J. Andres, and R.M. Feather-stone. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7: 88–95. Evidente, A., I. Iasiello, and G. Randazzo. 1984. Hippamine, a minor alkaloid from Sternbergia lutea. Journal of Natural Products 47: 1061–1062. Evidente, A., M. Rosaria Cicala, I. Giudicianni, G. Randazzo, and R. Riccio. 1983. 1H and 13c nmr analysis of lycorine and adihydrolycorine. Phytochemistry 22: 581–584. He, Q., Y. Shen, M. Wang, M. Huang, R. Yang, S. Zhu, L. Wang, Y. Xu, and R. Wu. 2011. Natural variation in petal color in Lycoris longituba revealed by anthocyanin components. PLoS One 6: e22098. Hiroko, S., H. Akihiro, and H. Tohru. 1993. The 1H- and 13C-nuclear magnetic resonance spectra of harman. Reinvestigation of the assignments by one- and two-dimensional methods. Chemical & Pharmaceutical Bulletin 41: 1169–1172. Ieven, M., B.D.A. Vanden, F. Mertens, A. Vlietinck, and E. Lammens. 1979. Screening of higher plants for biological activities. I. Antimicrobial activity. Planta medica 36: 311–321. Jin, A., X. Li, Y.Y. Zhu, H.Y. Yu, H.F. Pi, P. Zhang, and H.L. Ruan. 2014. Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl2 and H2O2-induced SH-

123

Y.-Y. Zhu et al. SY5Y cell injuries. Archives of Pharmacal Research 37: 315–323. Jin, J., and S.M. Weinreb. 1997. Application of a stereospecific intramolecular allenylsilane imino ene reaction to enantioselective total synthesis of the 5, 11-methanomorphanthridine class of amaryllidaceae alkaloids. Journal of the American Chemical Society 119: 5773–5784. Jin, Z. 2005. Amaryllidaceae and sceletium alkaloids. Natural Product Reports 22: 111–126. Jokhadze, M., L. Eristavi, J. Kutchukhidze, A. Chariot, L. Angenot, M. Tits, O. Jansen, and M. Frederich. 2007. In vitro cytotoxicity of some medicinal plants from Georgian Amaryllidaceae. Phytotherapy Research 21: 622–624. Kihara, M., L. Xu, K. Konishi, K. Kida, Y. Nagao, S. Kobayashi, and T. Shingu. 1994. Isolation and structure elucidation of a novel alkaloid, incartion, a supposed biosynthetic intermediate, from flowers of Lycoris incarnata. Chemical & Pharmaceutical Bulletin 42: 289–292. Kitagawa T., S. Uyeo, and N. Yokoyama. 1959. Stereochemistry of lycorenine, homolycorine, pluviine, and their hydrogenation products. Journal of the Chemical Society 3741–3751. Kornienko, A., and A. Evidente. 2008. Chemistry, biology and medicinal potential of narciclasine and its congeners. Chemical Reviews 108: 1982–2014. Li, L., J. Li, Y. Huang, Q. Wu, S. Deng, X. Su, R. Yang, J. Huang, Z. Chen, and S. Li. 2012. Lignans from the heartwood of Streblus asper and their inhibiting activities to Hepatitis B virus. Fitoterapia 83: 303–309. Li, X., H.Y. Yu, Z.Y. Wang, H.F. Pi, P. Zhang, and H.L. Ruan. 2013. Neuroprotective compounds from the bulbs of Lycoris radiata. Fitoterapia 88: 82–90. Li, Y., M. Zhao, and K.L. Parkin. 2011. b-Carboline derivatives and diphenols from soy sauce are in vitro quinone reductase (QR) inducers. Journal of Agricultural and Food Chemistry 59: 2332–2340. Liang, Y.Q., X. Feng, and Z.X. Zhao. 2010. The alkaloids in bulbs of lycoris longituba. Natural Product Research and Development 22: 241–244. Lopez, S., J. Bastida, F. Viladomat, and C. Codina. 2002. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and narcissus extracts. Life Sciences 71: 2521–2529. Louw, C.A., T.J. Regnier, and L. Korsten. 2002. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. Journal of Ethnopharmacology 82: 147–154. Matusch, R., M. Kreh, M.U. Ller, and U. Bildung. 1994. Kristallstruktur und absolute Konfiguration von (-)-N-(Chloromethyl)

123

galanthaminium-chlorid. Helvetica Chimica Acta 77: 1611–1615. McNulty, J., J.J. Nair, C. Codina, J. Bastida, S. Pandey, J. Gerasimoff, and C. Griffin. 2007. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids. Phytochemistry 68: 1068–1074. Pabuccuoglu V., P. Richomme, T. Gozler, B. Kivcak, A.J. Freyer, and M. Shamma. 1989. Four new crinine-type alkaloids from Sternbergia species. Journal of Natural Products 52: 785–791. Pearson, W.H., and B.W. Lian. 1998. Application of the 2-azaallyl anion cyclo-addition method to an enantioselective total synthesis of (?)-coccinine. Angewandte Chemie 37: 1724–1726. Perry, E.K. 1986. The cholinergic hypothesis—ten years on. British Medical Bulletin 42: 63–69. Roberts, J.D., W.O. Crain Jr, and W.C. Wildman. 1971. Nuclear magnetic resonance spectroscopy. Carbon-13 spectra of nicotine, quinine, and some Amaryllidaceae alkaloids. Journal of the American Chemical Society 93: 990–994. Sener, B., I. Orhan, and J. Satayavivad. 2003. Antimalarial activity screening of some alkaloids and the plant extracts from Amaryllidaceae. Phytotherapy Research 17: 1220–1223. Senol, F.S., I. Orhan, G. Yilmaz, M. Cicek, and B. Sener. 2010. Acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibition studies and antioxidant activities of 33 Scutellaria L. taxa from Turkey. Food and Chemical Toxicology 48: 781–788. Stanley, L.M., and J.F. Hartwig. 2009. Iridium-catalyzed regio- and enantioselective N-allylation of indoles. Angewandte Chemie 121: 7981–7984. Suau, R., A.I. Go´mez, and R. Rico. 1990. Ismine and related alkaloids from Lapiedra martinezii. 1712 29: 1710. Treu, M., and U. Jordis. 2001. 4aS, 6R, 8aS)-4a, 5, 9, 10, 11, 12-Hexahydro-6H-benzofuro [3a, 3, 2-ef][2] benzazepine-3, 6-diol (Norsanguinine. Molecules 6: M274. Tsuda, Y., T. Sano, J. Taga, K. Isobe, J. Toda, S. Takagi, M. Yamaki, M. Murata, H. Irie, and H. Tanaka. 1979. Total synthesis of the amaryllidaceae alkaloids, lycorine and zephyranthine. Journal of the Chemical Society, Perkin Transactions 1: 1358–1363. Wang, L., Z. Yin, Y. Cai, X. Zhang, X. Yao, and W. Ye. 2010. Amaryllidaceae alkaloids from the bulbs of Lycoris radiata. Biochemical Systematics and Ecology 38: 444–446. Wu, W.M., Y.Y. Zhu, H.R. Li, H.Y. Yu, P. Zhang, H.F. Pi, and H.L. Ruan. 2014. Two new alkaloids from the bulbs of Lycoris sprengeri. Journal of Asian Natural Products Research 16: 192–199. Zhao, Y., Y. Liang, Y. Chen, H. Sun, M. Wang, and X. Feng. 2011. Chemical constituents of bulbs of Lycoris longituba. Zhongyaocai 34: 1366–1368.

Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities.

Three novel alkaloids (1-3), together with nineteen known ones (4-22), were isolated from the bulbs of Lycoris longituba. Their structures were elucid...
609KB Sizes 0 Downloads 17 Views